Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ridolfi

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
A revised consideration on the use of very aged donors for liver transplantationG L Grazi, M Cescon, M Ravaioli, et al.
Chirurgia Italiana|October 9, 1999
[Liver transplantation from elderly donors]A Mazziotti, G L Grazi, M Cescon, et al.
Transplantation Proceedings|March 4, 2000
Evaluation of the efficiency of organ procurement and transplantation programA Ghirardini, A N Costa, S Venturi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 17, 2002
Hospital attitude survey on organ donation in the Emilia-Romagna region, ItalyM R Pugliese, D Degli Esposti, N Venturoli, et al.
Tumori|April 25, 2000
Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinomaM Fabbri, R Ridolfi, R Maltoni, et al.
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 15, 2000
Organ donation and transplantation as health programs in ItalyN Venturoli, S Venturi, S Taddei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Transplantation Proceedings|July 15, 2004
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cellsE Gabusi, B Corti, A D'Errico, et al.
Tumori|August 9, 2003
[Combined treatment of inoperable liver metastases from colorectal cancer]C Milandri, F Calzolari, E Giampalma, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2002
A revised consideration on the use of very aged donors for liver transplantationG L Grazi, M Cescon, M Ravaioli, et al.
Chirurgia Italiana|October 9, 1999
[Liver transplantation from elderly donors]A Mazziotti, G L Grazi, M Cescon, et al.
Transplantation Proceedings|March 4, 2000
Evaluation of the efficiency of organ procurement and transplantation programA Ghirardini, A N Costa, S Venturi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 17, 2002
Hospital attitude survey on organ donation in the Emilia-Romagna region, ItalyM R Pugliese, D Degli Esposti, N Venturoli, et al.
Tumori|April 25, 2000
Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinomaM Fabbri, R Ridolfi, R Maltoni, et al.
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 15, 2000
Organ donation and transplantation as health programs in ItalyN Venturoli, S Venturi, S Taddei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Transplantation Proceedings|July 15, 2004
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cellsE Gabusi, B Corti, A D'Errico, et al.
Tumori|August 9, 2003
[Combined treatment of inoperable liver metastases from colorectal cancer]C Milandri, F Calzolari, E Giampalma, et al.
Pageof 8